UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 158

Sortiert nach

IL-6 down-regulates HLA class II expression and IL-12 production of human dendritic cells to impair activation of antigen-specific CD4+ T cells

Cancer Immunology, Immunotherapy, 2016-02, Vol.65 (2), p.193-204

2016

Volltextzugriff (PDF)

The cytokine milieu compromises functional capacity of tumor-infiltrating plasmacytoid dendritic cells in HPV-negative but not in HPV-positive HNSCC

Cancer Immunology, Immunotherapy, 2021-09, Vol.70 (9), p.2545-2557

2021

Volltextzugriff (PDF)

A randomized controlled phase II clinical trial on mRNA electroporated autologous monocyte-derived dendritic cells (TriMixDC-MEL) as adjuvant treatment for stage III/IV melanoma patients who are disease-free following the resection of macrometastases

Cancer Immunology, Immunotherapy, 2020-12, Vol.69 (12), p.2589-2598

2020

Volltextzugriff (PDF)

The PI3Kδ inhibitor idelalisib impairs the function of human dendritic cells

Cancer Immunology, Immunotherapy, 2021-12, Vol.70 (12), p.3693-3700

2021

Volltextzugriff (PDF)

Immune activation of the monocyte-derived dendritic cells using patients own circulating tumor cells

Cancer Immunology, Immunotherapy, 2022-12, Vol.71 (12), p.2901-2911

2022

Volltextzugriff (PDF)

Human inflammatory dendritic cells in malignant pleural effusions induce Th1 cell differentiation

Cancer Immunology, Immunotherapy, 2020-05, Vol.69 (5), p.779-788

2020

Volltextzugriff (PDF)

TLR8 stimulation enhances cetuximab-mediated natural killer cell lysis of head and neck cancer cells and dendritic cell cross-priming of EGFR-specific CD8+ T cells

Cancer Immunology, Immunotherapy, 2013-08, Vol.62 (8), p.1347-1357

2013

Volltextzugriff (PDF)

Reviving up dendritic cells can run cancer immune wheel in non-small cell lung cancer: a prospective two-arm study

Cancer Immunology, Immunotherapy, 2021-03, Vol.70 (3), p.733-742

2021

Volltextzugriff (PDF)

Mycobacteria activate γδ T-cell anti-tumour responses via cytokines from type 1 myeloid dendritic cells: a mechanism of action for cancer immunotherapy

Cancer Immunology, Immunotherapy, 2012-04, Vol.61 (4), p.535-547

2012

Volltextzugriff (PDF)

A phase I/IIa clinical trial in stage IV melanoma of an autologous tumor–dendritic cell fusion (dendritoma) vaccine with low dose interleukin-2

Cancer Immunology, Immunotherapy, 2016-04, Vol.65 (4), p.383-392

2016

Volltextzugriff (PDF)

Dendritic cell-based vaccination of patients with advanced pancreatic carcinoma: results of a pilot study

Cancer Immunology, Immunotherapy, 2011-08, Vol.60 (8), p.1097-1107

2011

Volltextzugriff (PDF)

Monocyte-derived dendritic cells reflect the immune functional status of a chromophobe renal cell carcinoma patient: Could it be a general phenomenon?

Cancer Immunology, Immunotherapy, 2015-02, Vol.64 (2), p.161-171

2015

Volltextzugriff (PDF)

The chemotherapeutic agent topotecan differentially modulates the phenotype and function of dendritic cells

Cancer Immunology, Immunotherapy, 2013-08, Vol.62 (8), p.1315-1326

2013

Volltextzugriff (PDF)

The immune inhibitory receptor osteoactivin is upregulated in monocyte-derived dendritic cells by BCR–ABL tyrosine kinase inhibitors

Cancer Immunology, Immunotherapy, 2012-02, Vol.61 (2), p.193-202

2012

Volltextzugriff (PDF)

Effect of gemcitabine on immune cells in subjects with adenocarcinoma of the pancreas

Cancer Immunology, Immunotherapy, 2005-09, Vol.54 (9), p.915-925

2005

Volltextzugriff (PDF)

CD8+ T-cell priming and boosting: more antigen-presenting DC, or more antigen per DC?

Cancer Immunology, Immunotherapy, 2013-12, Vol.62 (12), p.1769-1780

2013

Volltextzugriff (PDF)

Exposure of CD34+ precursors to cytostatic anthraquinone-derivatives induces rapid dendritic cell differentiation: implications for cancer immunotherapy

Cancer Immunology, Immunotherapy, 2012-02, Vol.61 (2), p.181-191

2012

Volltextzugriff (PDF)

Activated human γδ T cells induce peptide-specific CD8+ T-cell responses to tumor-associated self-antigens

Cancer Immunology, Immunotherapy, 2012-03, Vol.61 (3), p.385-396

2012

Volltextzugriff (PDF)

FTY720 and SEW2871 reverse the inhibitory effect of S1P on natural killer cell mediated lysis of K562 tumor cells and dendritic cells but not on cytokine release

Cancer Immunology, Immunotherapy, 2010-04, Vol.59 (4), p.575-586

2010

Volltextzugriff (PDF)

Identification of novel MAGE-A6- and MAGE-A12-derived HLA-A24-restricted cytotoxic T lymphocyte epitopes using an in silico peptide-docking assay

Cancer Immunology, Immunotherapy, 2012-12, Vol.61 (12), p.2311-2319

2012

Volltextzugriff (PDF)

Decreased HPV-specific T cell responses and accumulation of immunosuppressive influences in oropharyngeal cancer patients following radical therapy

Cancer Immunology, Immunotherapy, 2013-12, Vol.62 (12), p.1821-1830

2013

Volltextzugriff (PDF)

Inclusive estimation of complex antigen presentation functions of monocyte-derived dendritic cells differentiated under normoxia and hypoxia conditions

Cancer Immunology, Immunotherapy, 2012-03, Vol.61 (3), p.409-424

2012

Volltextzugriff (PDF)

possible mechanism of intravesical BCG therapy for human bladder carcinoma: involvement of innate effector cells for the inhibition of tumor growth

Cancer Immunology, Immunotherapy, 2009-08, Vol.58 (8), p.1245-1255

2009

Volltextzugriff (PDF)

Dendritic cells in colorectal cancer correlate with other tumor-infiltrating immune cells

Cancer Immunology, Immunotherapy, 2004-11, Vol.53 (11), p.978-986

2004

Volltextzugriff (PDF)

Leukemic cell products down-regulate human dendritic cell differentiation

Cancer Immunology, Immunotherapy, 2010-11, Vol.59 (11), p.1645-1653

2010

Volltextzugriff (PDF)

1 – 25 von 158

Suche als RSS-Feed

Aktive Filter

ThemaAnimals

Zeitschrift / SerieCancer Immunology, Immunotherapy

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(158)
Mit Volltextzugriff
(158)

Publikationsform

Artikel
(158)

Sprache

Englisch
(158)
Japanisch
(15)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(158)
SpringerLink Journals - AutoHoldings
(158)
MEDLINE
(155)
Wiley Online Library Journals
(1)
Wiley Online Library
(1)
EZB Electronic Journals Library
(1)
Journals@Ovid Ovid Full Text
(1)

2 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Cancer Immunology Immunotherapy
(148)
Cancer Immunology, Immunotherapy : Cii
(140)
Cancer Immunology And Immunotherapy
(87)
International Journal Of Cancer
(1)

Menü

Weitere Dienste

Einstellungen

IL-6 down-regulates HLA class II expression and IL-12 production of human dendritic cells to impair activation of antigen-specific CD4+ T cells

The cytokine milieu compromises functional capacity of tumor-infiltrating plasmacytoid dendritic cells in HPV-negative but not in HPV-positive HNSCC

A randomized controlled phase II clinical trial on mRNA electroporated autologous monocyte-derived dendritic cells (TriMixDC-MEL) as adjuvant treatment for stage III/IV melanoma patients who are disease-free following the resection of macrometastases

The PI3Kδ inhibitor idelalisib impairs the function of human dendritic cells

Immune activation of the monocyte-derived dendritic cells using patients own circulating tumor cells

Human inflammatory dendritic cells in malignant pleural effusions induce Th1 cell differentiation

TLR8 stimulation enhances cetuximab-mediated natural killer cell lysis of head and neck cancer cells and dendritic cell cross-priming of EGFR-specific CD8+ T cells

Reviving up dendritic cells can run cancer immune wheel in non-small cell lung cancer: a prospective two-arm study

Mycobacteria activate γδ T-cell anti-tumour responses via cytokines from type 1 myeloid dendritic cells: a mechanism of action for cancer immunotherapy

A phase I/IIa clinical trial in stage IV melanoma of an autologous tumor–dendritic cell fusion (dendritoma) vaccine with low dose interleukin-2

Dendritic cell-based vaccination of patients with advanced pancreatic carcinoma: results of a pilot study

Monocyte-derived dendritic cells reflect the immune functional status of a chromophobe renal cell carcinoma patient: Could it be a general phenomenon?

The chemotherapeutic agent topotecan differentially modulates the phenotype and function of dendritic cells

The immune inhibitory receptor osteoactivin is upregulated in monocyte-derived dendritic cells by BCR–ABL tyrosine kinase inhibitors

Effect of gemcitabine on immune cells in subjects with adenocarcinoma of the pancreas

CD8+ T-cell priming and boosting: more antigen-presenting DC, or more antigen per DC?

Exposure of CD34+ precursors to cytostatic anthraquinone-derivatives induces rapid dendritic cell differentiation: implications for cancer immunotherapy

Activated human γδ T cells induce peptide-specific CD8+ T-cell responses to tumor-associated self-antigens

FTY720 and SEW2871 reverse the inhibitory effect of S1P on natural killer cell mediated lysis of K562 tumor cells and dendritic cells but not on cytokine release

Identification of novel MAGE-A6- and MAGE-A12-derived HLA-A24-restricted cytotoxic T lymphocyte epitopes using an in silico peptide-docking assay

Decreased HPV-specific T cell responses and accumulation of immunosuppressive influences in oropharyngeal cancer patients following radical therapy

Inclusive estimation of complex antigen presentation functions of monocyte-derived dendritic cells differentiated under normoxia and hypoxia conditions

possible mechanism of intravesical BCG therapy for human bladder carcinoma: involvement of innate effector cells for the inhibition of tumor growth

Dendritic cells in colorectal cancer correlate with other tumor-infiltrating immune cells

Leukemic cell products down-regulate human dendritic cell differentiation

Aktive Filter

Suchergebnisse filtern